|
| Ferrlecit Description:
Ferrlecit is used to treat iron deficiency anemia in patients on chronic hemodialysis who are receiving treatment to stimulate the production of red blood cells.
Active Ingredient: sodium ferric gluconate complex in sucrose injection
Strength(s): 12.5mg/ml
Dosage Form(s): intravenous injection |
Product Notes:
Who should not be treated with Ferrlecit? You should not be given Ferrlecit if you have an anemia that is not related to iron deficiency, or if you have iron overload.
Special Warnings with Ferrlecit:
Immediate allergic reactions to intravenous iron carbohydrate complexes can cause death. Preparation for appropriate resuscitation equipment is recommended.
Ferrlecit can cause a severe drop in blood pressure together with flushing, lightheadedness, weakness, fatigue, or severe pain in the chest, back or groin. Do not exceed recommended dosage levels. These reactions usually end within one or two hours.
General Precautions with Ferrlecit:
Iron is not easily eliminated from the body, and its build up can be toxic. Certain medical conditions may make you more likely to develop iron overload. Your doctor will decide if Ferrlecit is right for you.
Tell your health care provider if you are trying to become pregnant, are already pregnant, or are breast-feeding.
Ferrlecit contains benzyl alcohol and therefore should not be used in newborns. Side Effects:
Hypersensitivity reactions (see "Special Warnings")
Flushing and blood pressure drop (see "Special Warnings")
Other side effects may include:
Injection site reaction
Pain
Weakness
Headache
Abdominal pain
Fever
Feeling tired
Dizziness
Burning or prickling sensation
Shortness of breath
Diarrhea
Itching
Rash Manufacturer link or canadian Pharmacy drug sources: na
|
